Skip to content

Starting HIV treatment reduces the risk of serious non-AIDS-related diseases

Integrated analysis shows 'Quad' pill has potent activity with fewer side-effects

Chronic hepatitis C virus infection increases risk of death from both liver disease and non-liver-related causes

Atazanavir/ritonavir more likely to cause kidney stones than other ritonavir-boosted protease inhibitors

Starting HIV treatment reduces risk of kidney disease

Chronic hepatitis C infection more than doubles the risk of kidney disease for people with HIV

Diabetes increases risk of chronic kidney disease for people with HIV: effect greater than for either disease alone

HIV and TB in Practice for nurses: non-communicable diseases, HIV and TB

Tenofovir associated with increased risk of kidney disease